Mair Therapeutics
Mair Therapeutics develops small-molecule therapeutics aimed at treating motor symptoms of Parkinson's disease. The company focuses on discovering and optimizing an ion channel activator through preclinical drug discovery workflows. Its approach centers on medicinal chemistry, ion channel biology, and in vitro and in vivo pharmacology to advance lead compounds. Mair operates as a preclinical biopharma company positioned for research collaborations or licensing with larger pharmaceutical partners.
Mair Therapeutics
Mair Therapeutics develops small-molecule therapeutics aimed at treating motor symptoms of Parkinson's disease. The company focuses on discovering and optimizing an ion channel activator through preclinical drug discovery workflows. Its approach centers on medicinal chemistry, ion channel biology, and in vitro and in vivo pharmacology to advance lead compounds. Mair operates as a preclinical biopharma company positioned for research collaborations or licensing with larger pharmaceutical partners.